Aprea Therapeutics logo
Aprea Therapeutics APRE
$ 2.92 1.13%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Aprea Therapeutics EV/EBITDA Ratio 2011-2024 | APRE

Annual EV/EBITDA Ratio Aprea Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-248 -0.547 -3.18 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.547 -248 -84